tenk.fyi

Kyverna Therapeutics, Inc.

KYTXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$127.5M

111.2% YoY

EPS

$-3.33

96.3% YoY

Cash

$96.6M

178.9% YoY

FY 2024 · As of 2024-12-31